EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Haw Par's enterprise value is $-773.4 Mil.
Haw Par's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $173.3 Mil. Therefore, Haw Par's EV-to-Revenue for today is -4.46.
The historical rank and industry rank for Haw Par's EV-to-Revenue or its related term are showing as below:
HAWPY'
s EV-to-Revenue Range Over the Past 10 Years
Min: -7.99 Med: 0.03 Max: 9.53
Current: -4.51
During the past 13 years, the highest EV-to-Revenue of Haw Par was 9.53. The lowest was -7.99. And the median was 0.03.
HAWPY's EV-to-Revenue is ranked better than 99.71% of 1024
companies
in the Drug Manufacturers industry
Industry Median: 2.37
vs HAWPY: -4.51
As of today (2024-05-06), Haw Par's stock price is $28.64.
Haw Par's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.13. Therefore, Haw Par's PS Ratio for today is 9.14.
Haw Par EV-to-Revenue Historical Data
The historical data trend for Haw Par's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Haw Par's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Haw Par's EV-to-Revenue falls into.
Haw Par's current Enterprise Value is $-773.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Haw Par's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $173.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haw Par's share price for today is $28.64.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was $3.13.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haw Par EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Haw Par's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HAWPY has been successfully added to your 